Investment in R&D for the quarter was Rs 5,346 million

Lupin reported its financial performance for the quarter and fiscal year ending March 31, 2025. The Board has recommended a dividend of 600 per cent.

In Q4 FY2025, the gross profit was at Rs 38,760 million compared to Rs 33,213 million in Q4 FY2024, with a gross margin of 69.7 per cent. Personnel cost was 18 per cent of sales at Rs 10,013 million compared to Rs 9,002 million in Q4 FY2024. Manufacturing and other expenses were 30.3 per cent of sales at Rs 16,876 million compared to Rs 14,901 million in Q4 FY2024. PBT at Rs 8,958 million at 16.1 per cent, up 80 per cent YoY from Rs 4,977 million in Q4 FY2024. Investment in R&D for the quarter was Rs 5,346 million (9.6 per cent of sales).

Nilesh Gupta, MD, Lupin said, “We are delighted to end the last quarter and the year on a strong note. FY25 was led by strong growth in sales and profitability driven by in-line and new products, and consistent improvement in operating margins backed by strong commercial momentum and operational efficiencies. We are optimistic to continue this momentum in the year ahead.”